Aspen Biopharma Labs Pvt. product recalled over manufacturing violations
- Recall date
- February 7, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Aspen Biopharma Labs Pvt., Ltd. recalls Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and…
- Recall number
- D-0262-2025
- FDA classification
- Class II
- Brand / firm
- Aspen Biopharma Labs Pvt., Ltd.
- Sold / distributed
- Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
Why it was recalled
CGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.
Get recall alerts
Free email alert whenever Aspen Biopharma Labs Pvt., Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aspen Biopharma Labs Pvt., Ltd.